McKesson has agreed to pay $190 million to resolve allegations that the company fraudulently inflated the reported prices of several of its prescription drugs in an effort to manipulate Medicare’s Average Wholesale Price.  Over $2 billion has been recovered in AWP fraud cases filed against multiple drug manufacturers.

Read the press release, “McKesson Corp. Pays U.S. More Than $190 Million to Resolve False Claims Act Allegations”